Cybin Inc. Common Shares (NY:CYBN)

8.280 UNCHANGED

Last Price Updated: 8:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cybin Inc. Common Shares

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

41 42 Next >

Major Psychedelic Stock Downward Trend Continues ↗

October 24, 2022

The 8 constituents of our Psychedelic Drug Stocks Index continue to collectively show poor performance, down 4.6% more last week and now down 45.5% since the end of August.

Via Talk Markets

Allied, Small Pharma Among Top Psychedelic Movers Of Today ↗

October 21, 2022

GAINERS: Allied (OTC:ALID) shares closed up 10.21% at $0.53

Via Benzinga

Psychedelic Stock Gainers And Losers From October 18, 2022 ↗

October 18, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 15.76% at $0.14

Via Benzinga

Psychedelic Stock Gainers And Losers From October 17, 2022 ↗

October 17, 2022

GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 38.18% at $1.52

Via Benzinga

PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Continues Focus to Create the Best Psychedelic Therapies for Patients

October 17, 2022

Via Investor Brand Network

Small Pharma, Cybin Among Top Psychedelic Movers Of Today ↗

October 14, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.12% at $0.12

Via Benzinga

Psychedelic Stock Gainers And Losers From October 12, 2022 ↗

October 12, 2022

GAINERS: Allied (OTC:ALID) shares closed up 48.05% at $0.48

Via Benzinga

Numinus Wellness, Small Pharma Among Top Psychedelic Movers Of Today ↗

October 11, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 7.61% at $0.12

Via Benzinga

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), The Chopra Foundation Note World Mental Health Day

October 11, 2022

Via Investor Brand Network

Psychedelic Drugs Prove Their Worth In Clinical Trials

October 11, 2022

Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial...

Via PressReach

Psychedelic Stock Gainers And Losers From October 10, 2022 ↗

October 10, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 5.51% at $0.63 LOSERS:

Via Benzinga

Cybin & The Chopra Foundation Recognize World Mental Health Day

October 10, 2022

From Cybin Inc.

Via Business Wire

Psychedelic Drug Stocks Index Up Slightly This Week ↗

October 08, 2022

There are 8 stocks in the munKNEE Psychedelic Drug Stocks Index and this article reveals how its constituents performed this week, in descending order, since the end of August and YTD.

Via Talk Markets

Psychedelic Stock Gainers And Losers From October 6, 2022 ↗

October 06, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 45.41% at $0.22

Via Benzinga

PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) ‘Focused on Adding Targeted IP’

October 06, 2022

Via Investor Brand Network

Topics Intellectual Property

Cybin Provides Update on its Intellectual Property Portfolio

October 06, 2022

From Cybin Inc.

Via Business Wire

Colorado to Vote on Legalizing Psychoactives in November

October 05, 2022

Voters in Colorado will have a say in the legalization of psychedelic drugs this November as an initiative to legalize psilocybin mushrooms and other naturally occurring psychedelics appears on the...

Via PressReach

Topics Supply Chain

Allied, GH Research Among Top Psychedelic Movers Of Today ↗

October 04, 2022

GAINERS: Allied (OTC:ALID) shares closed up 31.58% at $0.60

Via Benzinga

Cybin, GH Research Among Top Psychedelic Movers Of Today ↗

October 03, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 20.50% at $0.58

Via Benzinga

September Cannabis Category Performances Ranged From -6.3% To -39.0% ↗

October 03, 2022

The performances of the 5 cannabis categories ranged from -6.3% to -39.0% in September, and are now -13.6% to -67.0%, YTD, depending on the category. The S&P 500, in comparison, was -8.6% in September...

Via Talk Markets

Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

September 30, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 2.08% at $0.49

Via Benzinga

Allied, Compass Pathways Among Top Psychedelic Movers Of Today ↗

September 29, 2022

GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 6.17% at $3.44

Via Benzinga

Psychedelic Stock Gainers And Losers From September 28, 2022 ↗

September 28, 2022

GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 10.48% at $1.16

Via Benzinga

Biomind Labs, Allied Among Top Psychedelic Movers Of Today ↗

September 27, 2022

GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 11.10% at $1.10

Via Benzinga

PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Enters Agreement to Obtain Novel Catalog of Psychedelic-Based Compounds

September 27, 2022

Via Investor Brand Network

Topics Intellectual Property

Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family ↗

September 27, 2022

Through its wholly-owned subsidiary, Cybin IRL Limited, Canadian-based psychedelics biotech Cybin Inc. (NYSE AMERICAN: CYBN) signed an agreement with next-gen psychedelics producer Mindset Pharma Inc.

Via Benzinga

Cybin Obtains Exclusive License to a Novel Catalog of Psychedelic-Based Compounds

September 27, 2022

From Cybin Inc.

Via Business Wire

Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

September 26, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.91% at $0.13

Via Benzinga

The 5 Cannabis Categories Fell Even Further Last Week ↗

September 26, 2022

The 5 categories in the cannabis sector performed quite differently from each other again last week. The ones that lost least are the most peripheral to the growing and/or distribution of cannabis.

Via Talk Markets

Psychedelic Stocks Continue To Plummet: -16% This Week; -33% MTD; Now -57% YTD ↗

September 25, 2022

Look at how the only psychedelic stocks with market caps larger than $50M gave performed this last week.

Via Talk Markets

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

41 42 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.